Nasogastric/Orogastric Tube Placement Confirmation in Neonates Utilizing Self-contained pH Device, a Feasibility Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

12 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-12

Study Completion Date

2025-01-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is looking at using a self-contained pH device that will assist in confirming placement of a nasogastric or orogastric tube placed in the stomach of hospitalized infants.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Nasogastric Indwelling Versus Oral Intermittent Tube Feeding Methods on Premature Infants

NCT00798824

Premature Infants

COMPLETED NA

Product Validation Study of RightSpot Infant pH Indicator for Rapid Bedside Verification of Proper Nasogastric (NG) Tube Placement in Newborn Intensive Care (NICU) Patients

NCT02279264

Establish Normative pH Values in Neonates

UNKNOWN

Gravitas Feeding Tube System Placement Validation in Neonates

NCT05914064

Nasogastric Tube

ACTIVE_NOT_RECRUITING NA

Gravitas Feeding Tube System Placement in Neonates

NCT05517707

Nasogastric Tube

COMPLETED

Nasogastric/Oral Gastric Tube Placement in Infants: Comparing 2 Measurement Methods

NCT01407991

Enteral Tube Placement

TERMINATED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Premature Birth

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Infants

Infants admitted to the University of Minnesota Masonic Children's Hospital neonatal intensive care unit.

nasogastric tube placement pH confirmation device

Intervention Type DEVICE

Each participation will get the contents tested by the novel device and the standard of care procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nasogastric tube placement pH confirmation device

Each participation will get the contents tested by the novel device and the standard of care procedure.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients admitted to the NICU at the University of Minnesota Masonic Children's Hospital, Minneapolis, MN requiring placement of an NG/OG tube are eligible to enroll.

Exclusion Criteria

* Participant deemed unsuitable for study by the treating provider. Participants who are on the following medications: proton-pump inhibitor (PPI's) or H2 blockers within one week prior to the device assessment.

Maximum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No